{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T04:36:41Z","timestamp":1721363801544},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1990,6,1]],"date-time":"1990-06-01T00:00:00Z","timestamp":644198400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[1990,6]]},"DOI":"10.1007\/bf02897204","type":"journal-article","created":{"date-parts":[[2008,4,29]],"date-time":"2008-04-29T17:34:42Z","timestamp":1209490482000},"page":"223-226","source":"Crossref","is-referenced-by-count":10,"title":["Evaluation of continuous-infusion alpha-difluoromethylornithine therapy for colorectal carcinoma"],"prefix":"10.1007","volume":"26","author":[{"given":"Jaffer A.","family":"Ajani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Ota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. Bruce","family":"Grossie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James L.","family":"Abbruzzese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack S.","family":"Faintuch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yehuda Z.","family":"Patt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane E.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Levin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Nishioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02897204_CR1","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1200\/JCO.1984.2.2.124","volume":"2","author":"MD Abeloff","year":"1984","unstructured":"Abeloff MD, Slavik M, Luk GD, Griffin CA, Hermann J, Blanc O, Sjoerdsma A, Baylin SB (1984) Phase I trial and pharmacokinetic studies of alpha-difluoromethylornithine. An inhibitor of polyamine synthesis. J Clin Oncol 2: 124\u2013130","journal-title":"J Clin Oncol"},{"key":"BF02897204_CR2","first-page":"5761","volume":"49","author":"JA Ajani","year":"1989","unstructured":"Ajani JA, Ota DM, Grossie VB, Levin B, Nishioka K (1989) Alterations in polyamine metabolism during continuous intravenous infusion of alpha-difluoromethylornithine: correlation of thrombocytopenia with alpha-difluoromethylornithine plasma levels. Cancer Res 49: 5761\u20135765","journal-title":"Cancer Res"},{"key":"BF02897204_CR3","first-page":"141","volume":"8","author":"JA Ajani","year":"1989","unstructured":"Ajani JA, Welch SR, Raber MN, Fields WS, Krakoff IH (1989) Comprehensive criteria for therapy-induced toxicity. Cancer Invest 8: 141\u2013153","journal-title":"Cancer Invest"},{"key":"BF02897204_CR4","first-page":"1497","volume":"43","author":"R Bjerkvig","year":"1983","unstructured":"Bjerkvig R, Oredsson SM, Marton LJ, Linden M, Deen DF (1983) Cell cycle age response of 9L cells to 1,3-bis(2-chloroethyl)-1-nitrosourea and modification by alpha-difluoromethylornithine. Cancer Res 43: 1497\u20131500","journal-title":"Cancer Res"},{"key":"BF02897204_CR5","first-page":"1068","volume":"46","author":"JM Ducore","year":"1986","unstructured":"Ducore JM, McNamara L (1986) Effect of alpha-difluoromethylornithine onl-phenylalanine mustard-induced cytotoxicity and DNA interstrand cross-linking in a human cell line in vitro. Cancer Res 46: 1068\u20131072","journal-title":"Cancer Res"},{"key":"BF02897204_CR6","first-page":"1836","volume":"47","author":"VB Grossie","year":"1987","unstructured":"Grossie VB, Ota DM, Ajani JA, Nishioka K (1987) Effect of intravenous alpha-difluoromethylornithine on the polyamine levels of normal tissue and transplantable fibrosarcoma. Cancer Res 47: 1836\u20131840","journal-title":"Cancer Res"},{"key":"BF02897204_CR7","first-page":"4159","volume":"49","author":"VB Grossie","year":"1989","unstructured":"Grossie VB, Ota DM, Ajani JA, Chang TH, Patenia D, Nishioka K (1989) Reduction of difluoromethyl-ornithine-induced thrombocytopenia with ornithine while maintaining anti-tumor activity. Cancer Res 49: 4159\u20134162","journal-title":"Cancer Res"},{"key":"BF02897204_CR8","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/1097-0142(19840315)53:6<1294::AID-CNCR2820530612>3.0.CO;2-M","volume":"53","author":"HW Herr","year":"1984","unstructured":"Herr HW, Kleinert EL, Relyea NM, Whitmore WF (1984) Potentiation of methylglyoxal-bis-guanylhydrazone by alpha-difluoromethylornithine in rat prostate cancer. Cancer 53: 1294\u20131298","journal-title":"Cancer"},{"key":"BF02897204_CR9","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1073\/pnas.78.4.2355","volume":"78","author":"GD Luk","year":"1981","unstructured":"Luk GD, Goodwin G, Marton LJ, Baylin SB (1981) Polyamines are needed for the survival of human small-cell lung carcinoma in culture. Proc Natl Acad Sci USA 78: 2355\u20132358","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02897204_CR10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF00179433","volume":"3","author":"AM Maddox","year":"1985","unstructured":"Maddox AM, Keating MJ, McCredie KE, Estey E, Freireich EJ (1985) Phase I study of intravenous difluoromethylornithine \u2014 a polyamine inhibitor. Invest New Drugs 3: 287\u2013292","journal-title":"Invest New Drugs"},{"key":"BF02897204_CR11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0006-291X(78)91630-3","volume":"81","author":"PS Mamont","year":"1978","unstructured":"Mamont PS, Duchesne MC, Grove J, Bey P (1978) Antiproliferative properties ofDL-alpha-difluoromethyl ornithine in cultured cells. A consequence of the irreversible inhibition of ornithine decarboxylase. Biochem Biophys Res Commun 81: 58\u201366","journal-title":"Biochem Biophys Res Commun"},{"key":"BF02897204_CR12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1432-1033.1984.tb08308.x","volume":"142","author":"PS Mamont","year":"1984","unstructured":"Mamont PS, Siat M, Joder-Ohlenbusch AM, Bernhardt A, Casara P (1984) Effect of (2R, 5R)-6-heptyne-2,5-diamine, a potent inhibitor ofl-ornithine decarboxylase, on rat hepatoma cells cultured in vitro. Eur J Biochem 142: 457\u2013463","journal-title":"Eur J Biochem"},{"key":"BF02897204_CR13","first-page":"1","volume-title":"Inhibition of polyamine metabolism. Biologic significance and basis for new therapies","author":"PP McCann","year":"1987","unstructured":"McCann PP, Pegg AE, Sjoerdsma A (1987) Inhibition of polyamine metabolism. Biologic significance and basis for new therapies. Academic Press, Orlando, Florida, pp 1\u2013371"},{"key":"BF02897204_CR14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1042\/bj2340249","volume":"234","author":"AE Pegg","year":"1986","unstructured":"Pegg AE (1986) Recent advances in the biochemistry of polyamines in eukaryotes. Biochem J 234: 249\u2013262","journal-title":"Biochem J"},{"key":"BF02897204_CR15","first-page":"759","volume":"48","author":"AE Pegg","year":"1988","unstructured":"Pegg AE (1988) Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res 48: 759\u2013774","journal-title":"Cancer Res"},{"key":"BF02897204_CR16","doi-asserted-by":"crossref","first-page":"C212","DOI":"10.1152\/ajpcell.1982.243.5.C212","volume":"243","author":"AE Pegg","year":"1982","unstructured":"Pegg AE, McCann PP (1982) Polyamine metabolism and function. Am J Physiol 243: C212-C221","journal-title":"Am J Physiol"},{"key":"BF02897204_CR17","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1021\/bi00350a016","volume":"25","author":"AE Pegg","year":"1986","unstructured":"Pegg AE, Wechter RS, Clark RS, Wiest L, Erwin BG (1986). Acetylation of decarboxylatedS-adenosylmethionine by mammalian cells. Biochemistry 25: 379\u2013384","journal-title":"Biochemistry"},{"key":"BF02897204_CR18","first-page":"1148","volume":"46","author":"PJ Pera","year":"1986","unstructured":"Pera PJ, Kramer DL, Sufrin JR, Porter CW (1986) Comparison of the biological effects of four irreversible inhibitors of ornithine decarboxylase in two murine lymphocytic leukemia cell lines. Cancer Res 46: 1148\u20131154","journal-title":"Cancer Res"},{"key":"BF02897204_CR19","first-page":"2132","volume":"45","author":"J Seidenfeld","year":"1985","unstructured":"Seidenfeld J, Komar KA (1985) Chemosensitization of cultured human carcinoma cells to 1,3-bis(2-chloroethyl)-1-nitrosourea by difluoromethylornithine-induced polyamine depletion. Cancer Res 45: 2132\u20132138","journal-title":"Cancer Res"},{"key":"BF02897204_CR20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0014-4827(81)90420-1","volume":"131","author":"J Seidenfeld","year":"1981","unstructured":"Seidenfeld J, Gray JW, Marton LJ (1981) Depletion of 9L rat brain cell polyamine content by treatment withD,L-alpha-difluoromethylornithine inhibits proliferation and the G1 to S transition. Exp Cell Res 131: 209\u2013216","journal-title":"Exp Cell Res"},{"key":"BF02897204_CR21","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/clpt.1984.33","volume":"35","author":"A Sjoerdsma","year":"1984","unstructured":"Sjoerdsma A, Schechter PJ (1984) Chemotherapeutic implications of polyamine biosynthesis inhibition. Clin Pharmacol Ther 35: 287\u2013300","journal-title":"Clin Pharmacol Ther"},{"key":"BF02897204_CR22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0277-5379(86)90343-3","volume":"22","author":"TAW Splinter","year":"1986","unstructured":"Splinter TAW, Romjin JC (1986) Phase I study of alpha-difluoromethylornithine and methyl-GAG. Eur J Clin Oncol 22: 61\u201367","journal-title":"Eur J Clin Oncol"},{"key":"BF02897204_CR23","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0006-291X(80)90755-X","volume":"95","author":"PS Sunkara","year":"1980","unstructured":"Sunkara PS, Fowler SK, Nishioka K, Rao PN (1980) Inhibition of polyamine biosynthesis by alpha-difluoromethylornithine potentiates the cytotoxic effects of arabinosyl cytosine in HeLa cells. Biochem Biophys Res Commun 95: 423\u2013430","journal-title":"Biochem Biophys Res Commun"},{"key":"BF02897204_CR24","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1146\/annurev.bi.53.070184.003533","volume":"53","author":"CW Tabor","year":"1984","unstructured":"Tabor CW, Tabor H (1984) Polyamines. Annu Rev Biochem 53: 749\u2013790","journal-title":"Annu Rev Biochem"},{"key":"BF02897204_CR25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1128\/MMBR.49.1.81-99.1985","volume":"49","author":"CW Tabor","year":"1985","unstructured":"Tabor CW, Tabor H (1985) Polyamines in microorganisms. Microbiol Rev 49: 81\u201399","journal-title":"Microbiol Rev"},{"key":"BF02897204_CR26","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/BF00254263","volume":"11","author":"RP Warrell","year":"1983","unstructured":"Warrell RP, Coonley CJ, Burchenal JH (1983) Sequential inhibition of polyamine synthesis: a phase I trial of DFMO (alpha-difluoromethylornithine) and methyl-GAG[methylglyoxal-bis(guanylhydrazone)]. Cancer Chemother Pharmacol 11: 134\u2013136","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF02897204_CR27","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1353\/pbm.1979.0013","volume":"22","author":"HG Williams-Ashman","year":"1979","unstructured":"Williams-Ashman HG, Canellakis ZN (1979) Polyamines in mammalian biology and medicine. Perspect Biol Med 22: 421\u2013453","journal-title":"Perspect Biol Med"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02897204.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02897204\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02897204","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T22:36:15Z","timestamp":1588631775000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02897204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,6]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1990,6]]}},"alternative-id":["BF02897204"],"URL":"https:\/\/doi.org\/10.1007\/bf02897204","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,6]]}}}